Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This herbal tea is a combination product consisting of tulsi (*Ocimum sanctum*), guava (*Psidium guajava*), and stevia (*Stevia rebaudiana*), developed by Composite Interceptive Med Science. It is designed as a low-cost, high-quality intervention for glycemic control in subjects with early Type 2 Diabetes. Tulsi and guava are traditionally recognized for their hypoglycemic properties, potentially improving insulin sensitivity and pancreatic beta-cell function, while stevia serves as a natural, non-caloric sweetener that may also contribute to glucose metabolism regulation. The product is administered as an infusion via tea bags taken before meals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tulsi + guava + stevia herbal tea.